Brian Berger, MD

Clinical Assistant Professor

1972 …2018
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Bio

Dr. Berger received his MD from the University of Chicago, completed his residency at the University of Illinois-Chicago and fellowship in retinal surgery at the Eye Institute of the Medical College of Wisconsin. He is Board Certified by the American Board of Ophthalmology. Dr. Berger sees patients by referral only for the management of retinal diseases and uveitis.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Vitrectomy Medicine & Life Sciences
Macular Edema Medicine & Life Sciences
Visual Acuity Medicine & Life Sciences
Retinal Perforations Medicine & Life Sciences
Vascular Endothelial Growth Factor A Medicine & Life Sciences
Lasers Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1972 2018

1 Citation (Scopus)

A CCR2/5 inhibitor, PF-04634817, is inferior to monthly ranibizumab in the treatment of diabetic macular edema

Gale, J. D., Berger, B., Gilbert, S., Popa, S., Sultan, M. B., Schachar, R. A., Girgenti, D. & Perros-Huguet, C., May 1 2018, In : Investigative Ophthalmology and Visual Science. 59, 6, p. 2659-2669 11 p.

Research output: Contribution to journalArticle

Open Access
Macular Edema
Visual Acuity
Arm
Placebos
Therapeutics
2 Citations (Scopus)

A phase 1, open-label, dose-escalation trial to investigate safety and tolerability of single intravitreous injections of ICON-1 targeting tissue factor in wet AMD

Wells, J. A., Gonzales, C. R., Berger, B., Gonzalez, V. H., Sippy, B. D. & Burian, G., May 1 2018, In : Ophthalmic Surgery Lasers and Imaging Retina. 49, 5, p. 336-345 10 p.

Research output: Contribution to journalArticle

Thromboplastin
Choroidal Neovascularization
Safety
Injections
Macular Degeneration
2 Citations (Scopus)
Macular Edema
Vascular Endothelial Growth Factor A
Randomized Controlled Trials
Injections
Appointments and Schedules
25 Citations (Scopus)

Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: A DRCR network phase 2 randomized clinical trial

Diabetic Retinopathy Clinical Research Network, Jan 1 2018, In : JAMA Ophthalmology. 136, 1, p. 29-38 10 p.

Research output: Contribution to journalArticle

Macular Edema
Dexamethasone
Randomized Controlled Trials
Vascular Endothelial Growth Factor A
Visual Acuity
3 Citations (Scopus)

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

Diabetic Retinopathy Clinical Research Network, Jul 1 2018, In : Ophthalmology. 125, 7, p. 1054-1063 10 p.

Research output: Contribution to journalArticle

Endothelial Growth Factors
Macular Edema
Vascular Endothelial Growth Factor A
Therapeutics
Injections